Development of Carbohydrate Polyelectrolyte Nanoparticles for Use in Drug Delivery Systems that Cross the Blood-Brain Barrier to Treat Brain Tumors.

Statistical differences were considered significant if p -values were less than 0.05 (* p ≤ 0.05) and highly significant if p -values were less than 0.01 (** p ≤ 0.01), less than 0.001 (*** p ≤ 0.001), or less than 0.0001 (**** p ≤ 0.0001).

also in 82,756 other papers

A notable trend was observed: the diameter increased as the chitosan concentration in the starting mixture rose.

also in 2,135 other papers